CLBS logo

Caladrius Biosciences (CLBS) Non Current Assets

CLBS Annual Non Current Assets

$826.00 K
+$155.00 K+23.10%

31 December 2021

CLBS Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLBS Quarterly Non Current Assets

$1.24 M
-$9.69 M-88.66%

01 September 2022

CLBS Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLBS Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+23.1%+187.5%
3 y3 years+74.3%-13.2%
5 y5 years-58.3%-30.5%

CLBS Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-99.3%-99.0%

Caladrius Biosciences Non Current Assets History

DateAnnualQuarterly
Sept 2022
-
$1.24 M(-88.7%)
June 2022
-
$10.93 M(+1332.5%)
Mar 2022
-
$763.00 K(-7.6%)
Dec 2021
$96.18 M(+172.2%)
$826.00 K(+91.6%)
Sept 2021
-
$431.00 K(-19.3%)
June 2021
-
$534.00 K(-7.0%)
Mar 2021
-
$574.00 K(-14.5%)
Dec 2020
$35.33 M(+36.0%)
$671.00 K(-11.8%)
Sept 2020
-
$761.00 K(-11.0%)
June 2020
-
$855.00 K(-8.5%)
Mar 2020
-
$934.00 K(-20.9%)
Dec 2019
$25.97 M(-41.1%)
$1.18 M(-17.2%)
Sept 2019
-
$1.43 M(-6.9%)
June 2019
-
$1.53 M(-6.7%)
Mar 2019
-
$1.64 M(+246.4%)
Dec 2018
$44.11 M(-28.2%)
$474.00 K(-21.1%)
Sept 2018
-
$600.80 K(+11.1%)
June 2018
-
$540.90 K(-75.3%)
Mar 2018
-
$2.19 M(+10.5%)
Dec 2017
$61.40 M(+149.1%)
$1.98 M(+11.1%)
Sept 2017
-
$1.78 M(-2.9%)
June 2017
-
$1.84 M(-93.1%)
Mar 2017
-
$26.59 M(-7.9%)
Dec 2016
$24.65 M(-15.8%)
$28.87 M(+5.7%)
Sept 2016
-
$27.31 M(-0.5%)
June 2016
-
$27.46 M(-0.4%)
Mar 2016
-
$27.57 M(-1.3%)
Dec 2015
$29.27 M(-19.3%)
$27.93 M(-35.9%)
Sept 2015
-
$43.55 M(-46.3%)
June 2015
-
$81.15 M(-9.6%)
Mar 2015
-
$89.80 M(-0.2%)
Dec 2014
$36.28 M(-28.6%)
$89.99 M(+0.1%)
Sept 2014
-
$89.92 M(-2.8%)
June 2014
-
$92.54 M(+132.3%)
Mar 2014
-
$39.84 M(+2.2%)
Dec 2013
$50.83 M(+204.2%)
$38.99 M(+4.1%)
Sept 2013
-
$37.45 M(-1.5%)
June 2013
-
$38.02 M(+2.1%)
Mar 2013
-
$37.22 M(-1.3%)
Dec 2012
$16.71 M(-56.7%)
$37.70 M(-53.4%)
Sept 2012
-
$80.92 M(-5.7%)
June 2012
-
$85.77 M(-25.0%)
Mar 2012
-
$114.31 M(-2.1%)
Dec 2011
$38.61 M(-17.6%)
$116.72 M(-5.2%)
Sept 2011
-
$123.12 M(-3.0%)
June 2011
-
$126.97 M(+1.3%)
Mar 2011
-
$125.37 M(+30.4%)
Dec 2010
$46.88 M
$96.14 M(+8.4%)
DateAnnualQuarterly
Sept 2010
-
$88.71 M(+4.3%)
June 2010
-
$85.09 M(+6.1%)
Mar 2010
-
$80.18 M(+1.1%)
Dec 2009
$31.80 M(+5895.3%)
$79.28 M(+3481.0%)
Sept 2009
-
$2.21 M(+50.6%)
June 2009
-
$1.47 M(+15.7%)
Mar 2009
-
$1.27 M(-1.9%)
Dec 2008
$530.40 K(-77.7%)
$1.29 M(-5.4%)
Sept 2008
-
$1.37 M(+0.5%)
June 2008
-
$1.36 M(-1.8%)
Mar 2008
-
$1.39 M(-1.0%)
Dec 2007
$2.38 M(+349.7%)
$1.40 M(+100.9%)
Sept 2007
-
$696.90 K(+5.2%)
June 2007
-
$662.30 K(-0.6%)
Mar 2007
-
$666.00 K(-0.1%)
Dec 2006
$528.20 K(+4.1%)
$666.80 K(+4.4%)
Sept 2006
-
$638.60 K(-3.6%)
June 2006
-
$662.60 K(-1.6%)
Mar 2006
-
$673.50 K(+397.4%)
Dec 2005
$507.30 K(+933.2%)
$135.40 K(+365.3%)
Sept 2005
-
$29.10 K(-17.6%)
June 2005
-
$35.30 K(-16.7%)
Mar 2005
-
$42.40 K(-15.7%)
Dec 2004
$49.10 K(-78.6%)
$50.30 K(-14.2%)
Sept 2004
-
$58.60 K(-4.1%)
June 2004
-
$61.10 K(-4.8%)
Mar 2004
-
$64.20 K(-22.4%)
Dec 2003
$229.00 K(-78.4%)
$82.70 K(-11.2%)
Sept 2003
-
$93.10 K(-10.6%)
June 2003
-
$104.10 K(-9.1%)
Mar 2003
-
$114.50 K(-7.5%)
Dec 2002
$1.06 M(-32.7%)
$123.80 K(-12.4%)
Sept 2002
-
$141.30 K(-11.1%)
June 2002
-
$159.00 K(-32.6%)
Mar 2002
-
$235.90 K(-9.9%)
Dec 2001
$1.57 M(-37.9%)
$261.90 K(-57.0%)
Sept 2001
-
$609.30 K(-38.9%)
June 2001
-
$998.00 K(+1.4%)
Mar 2001
-
$984.10 K(-19.4%)
Dec 2000
$2.54 M(-42.9%)
$1.22 M(+99.9%)
Sept 2000
-
$610.60 K(-4.6%)
June 2000
-
$639.90 K(-4.9%)
Mar 2000
-
$672.60 K
Dec 1999
$4.44 M(+432.6%)
-
Dec 1998
$834.50 K(-26.1%)
-
Mar 1998
$1.13 M(+7852.1%)
-
Mar 1997
$14.20 K(-89.5%)
-
Mar 1996
$135.10 K
-

FAQ

  • What is Caladrius Biosciences annual long term assets?
  • What is the all time high annual non current assets for Caladrius Biosciences?
  • What is Caladrius Biosciences annual non current assets year-on-year change?
  • What is Caladrius Biosciences quarterly long term assets?
  • What is the all time high quarterly non current assets for Caladrius Biosciences?
  • What is Caladrius Biosciences quarterly non current assets year-on-year change?

What is Caladrius Biosciences annual long term assets?

The current annual non current assets of CLBS is $826.00 K

What is the all time high annual non current assets for Caladrius Biosciences?

Caladrius Biosciences all-time high annual long term assets is $116.72 M

What is Caladrius Biosciences annual non current assets year-on-year change?

Over the past year, CLBS annual long term assets has changed by +$155.00 K (+23.10%)

What is Caladrius Biosciences quarterly long term assets?

The current quarterly non current assets of CLBS is $1.24 M

What is the all time high quarterly non current assets for Caladrius Biosciences?

Caladrius Biosciences all-time high quarterly long term assets is $126.97 M

What is Caladrius Biosciences quarterly non current assets year-on-year change?

Over the past year, CLBS quarterly long term assets has changed by +$808.00 K (+187.47%)